.jpg "Emily Nieves photo")
Co-founder/ CEO
Delineate Inc.
Emily Nieves received her bachelor's degree in Biological Engineering from the University of Georgia, where she spent significant time working in the Hallow cardiorenal lab. She has previously worked on Quantitative Systems Pharmacology and machine learning models for applications spanning the cardiorenal system, metabolism, and cell therapies for companies like Pfizer and AstraZeneca. She is also a PhD candidate in biological engineering at MIT, where she studies hybrid AI and scientific machine learning algorithms. Emily is currently co-founder and CEO of Delineate, a seed-stage startup focused on applying large language models and other AI techniques to accelerate MIDD workflows.